How Amyloidosis Medications Work

Amyloidosis is a group of diseases characterized by the accumulation of abnormal proteins, called amyloid fibrils, in various organs and tissues. These deposits can disrupt normal organ function, leading to symptoms such as cardiac dysfunction, nephrological symptoms, neurological symptoms, and gastrointestinal symptoms.

Gold Standard Treatment: Chimeric (MoAb) Therapy

The gold standard treatment for amyloidosis is chimeric monoclonal antibody therapy. This involves the use of a monoclonal antibody that targets and binds to specific epitopes on the surface of amyloid fibrils, marking them for destruction by the immune system.

Alternative Treatments

• Cyclophosphamide: A chemotherapy agent that can help reduce amyloid production and promote its clearance from the body.
• Melphalan: Another chemotherapy agent that has been shown to be effective in reducing amyloid deposits and improving organ function.
• Rituximab: A monoclonal antibody that targets CD20-positive cells, which can help reduce the production of abnormal proteins.

Key Principles

The goal of treatment in amyloidosis is to reduce the accumulation of amyloid fibrils and promote their clearance from affected organs. This can be achieved through various mechanisms, including the use of monoclonal antibodies that target specific epitopes on the surface of amyloid fibrils, or chemotherapy agents that reduce amyloid production and promote its clearance.